Anxiety disorder
698 results
101 - 200
First-line treatment for social anxiety disorder: cognitive behavioral therapy- Mindfulness-based stress reduction is noninferior to escitalopram for adults with anxiety disorder
- Escitalopram (Lexapro) minimally effective for generalized anxiety disorder in older adults
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults 
Augmentation of cognitive and behavioural therapies (CBT) with d‐cycloserine for anxiety and related disorders- Useful screening tools for generalized anxiety and panic disorder
- One third of patients with anxiety disorder will relapse when SSRI/SNRI treatment stops
- Pharmacotherapy for social anxiety disorder (SAnD)
- Antidepressants for generalised anxiety disorder (GAD): Cochrane systematic review
- Pharmacotherapy for anxiety disorders in children and adolescents: Cochrane systematic review
- CBT, sertraline, and combination effective for childhood anxiety disorders
- Hydroxyzine for generalised anxiety disorder: Cochrane systematic review
- Cognitive behavioural therapy and third‐wave approaches for anxiety and related disorders in older people
- Psychological therapies for generalised anxiety disorder
- Cognitive behavioural therapy for anxiety disorders in children and adolescents
- Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults
- Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- The diagnostic accuracy of widely used self‐report questionnaires for detecting anxiety disorders in adults
- Multiple drugs in several classes are effective and well tolerated in patients with generalized anxiety disorder
- Morita therapy for anxiety disorders in adults: Cochrane systematic review
- Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adults: Cochrane systematic review
- Antidepressants versus placebo for generalised anxiety disorder (GAD)
- Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
- Treatment of depression in association with other psychiatric disorders
- Mental disorders during pregnancy
- USPSTF 2022: Screening for anxiety is recommended in children and adolescents aged 8 to 18 years (B recommendation)
- Childhood panic disorder
- Psychological treatment for anxiety in people with traumatic brain injury
- A patient with psychosomatic symptoms
- USPSTF 2023: Screening recommended for anxiety in adults, including in pregnant and postpartum persons (B recommendation)
- Exercise for the treatment of anxiety in children and adolescents
- Obsessive-compulsive disorder (OCD)
- Dyspepsia
- Psychiatric evaluation and referral to treatment of adolescents
- Eszopiclone and escitalopram useful for anxiety and insomnia
- Recognition and diagnostics of depression
- Obsessive-compulsive disorder (OCD) in children
- Fluoxetine may offer advantages over other anxiety treatments
- Treatment of drug addicts
- Premenstrual syndrome (PMS)
- Acute stress reaction and post-traumatic stress disorder
- Adjustment disorders in childhood
- Psychiatric evaluation of an adult
- Oral CBD promising for treatment of heroin use disorder
- ADHD
- Psychotherapies for adults
- Medical cannabis use not supported by a wealth of research
- Prenatal cannabis exposure is not associated with an increased incidence of several neuropsychiatric disorders
- Selective mutism